ТОР10 OTC drug launches in the out-of-pocket segment of Russia’s pharma market by sales, 2013*
Rank |
ТМ |
Corporation |
2nd level АТС group** |
Sales (mn RUB) |
1 |
Vicks Active Symptomax |
Teva |
R05 — Cold and cough preparations |
80.51 |
2 |
Zovirax Duo-Active |
GSK |
D06 — Topical antibacterials and antivirals |
32.64 |
3 |
Troxevasin Neo |
Actavis |
C05 — Antivaricosis / Antihaemorrhodeal preparations |
15.86 |
4 |
Calcium D3-MIC |
Minskinterkaps |
A12 — Mineral supplements |
14.3 |
5 |
Generolon |
Belupo |
D11 — Other dermatological preparations |
11.67 |
6 |
Rhinomaris |
Jadran |
R01 — Nasal preparations |
8.65 |
7 |
Fungoterbine Neo |
STADA |
D01 — Antifungals, dermatological |
7.89 |
8 |
Nasic for children |
MKM Klosterfrau Vert |
R01 — Nasal preparations |
6.51 |
9 |
Afrin extro |
Merck Sharp & Dohme |
R01 — Nasal preparations |
6.12 |
10 |
Lactoginal |
Besins International |
G01 — Gynecological anti-infectives |
6.06 |
* Trademark rebranding not considered
** Hereinafter — WHO classification